Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/tazobactam pharmacokinetics in pediatric and young adult hematology/oncology patients with augmented renal clearance
2016-003374-40Phase 4Completed
- Sponsor
- University of Tartu
- Start
- Oct 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of piperacillin + tazobactam in bacterial disease (2 arms), sponsored by University of Tartu. Primary endpoint: Pharmacokinetics of piperacillin/tazobactam. Started Oct 2016; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2016-003374-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003374-40.